(Q47931102)

6 February 2018

title

A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours. (English)

1 reference

6 February 2018

1 reference

Garcia-Prats MD

1

1 reference

6 February 2018

Ballestin C

2

1 reference

6 February 2018

Sotelo T

3

1 reference

6 February 2018

Lopez-Encuentra A

4

1 reference

6 February 2018

Mayordomo JI

5

1 reference

6 February 2018

publication date

1 May 1998

1 reference

6 February 2018

published in

Histopathology

1 reference

6 February 2018

volume

32

1 reference

6 February 2018

page(s)

462-472

1 reference

6 February 2018

issue

5

1 reference

6 February 2018

Immunohistological study of malignant diffuse mesotheliomas of the pleura

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

The use of vimentin antibodies in the diagnosis of malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

The value of immunohistochemistry of pleural biopsy specimens in the differential diagnosis between malignant mesothelioma and metastatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

The influence of protease digestion and duration of fixation on the immunostaining of keratins. A comparison of formalin and ethanol fixation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

Localized fibrous tumor of the serosal cavities. Immunohistochemical, electron-microscopic, and flow-cytometric DNA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

Ultrastructural diagnosis of epithelial malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

Diffuse epithelial mesothelioma: a review of the ultrastructural spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

Characteristics of nine newly derived mesothelioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

Tumour marker immunoreactivity in adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

Intermediate filament expression in mesotheliomas: leiomyoid mesotheliomas are not uncommon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

Monoclonal antibodies to human malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00405.X

10.1046/J.1365-2559.1998.00405.X

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

9639123

1 reference

6 February 2018